Neuren Pharmaceuticals

Neuren Pharmaceuticals Limited is a biopharmaceutical company dedicated to developing drugs for brain injury and neurodegeneration. These drugs aim to target acute indications of traumatic brain injury, such as traumatic brain injury, as well as chronic conditions like Parkinson's disease and Alzheimer's disease. Neuren is also engaged in the research and development of metabolic disorders, such as cancers related to growth hormone function.